Literature DB >> 20670156

Soluble endoglin for the prediction of preeclampsia in a high risk cohort.

Sharon E Maynard1, Tiffany A Moore Simas, Lana Bur, Sybil L Crawford, Matthew J Solitro, Bruce A Meyer.   

Abstract

OBJECTIVES: To evaluate soluble endoglin (sEng) and the soluble fms-like tyrosine kinase 1 (sFlt1) to placental growth factor (PlGF) ratio for the prediction of preeclampsia in high-risk women, and to evaluate differences in sEng between women with high-risk singleton and multiple gestation pregnancies. STUDY
DESIGN: We collected serial serum specimens from 119 women at high preeclampsia risk. sEng, sFlt1 and PlGF were measured by ELISA.
RESULTS: Among subjects who did not develop preeclampsia, mean serum sEng was significantly higher in those with multiple gestation pregnancies vs. high-risk singletons. Among women with singleton gestations, mean serum sEng was higher in subjects who developed early-onset (<34 weeks) and late-onset (>or= 34 weeks) preeclampsia, as compared with subjects without preeclampsia, from 22 weeks and 28 weeks gestation onward, respectively. The within-woman rate of change of sEng was also higher in women who later developed preeclampsia.
CONCLUSIONS: sEng is higher in women with multiple gestations vs. high-risk singleton pregnancies. In high-risk women, serum sEng is increased prior to preeclampsia onset.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20670156     DOI: 10.3109/10641950902968684

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  6 in total

1.  Maternal plasma concentrations of angiogenic/anti-angiogenic factors are of prognostic value in patients presenting to the obstetrical triage area with the suspicion of preeclampsia.

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Zeynep Alpay Savasan; Juan Pedro Kusanovic; Giovanna Ogge; Eleazar Soto; Zhong Dong; Adi Tarca; Bhatti Gaurav; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2011-08-09

2.  Biochemical markers in the pathogenesis of preeclampsia: novel link between placental growth factor and interleukin-6.

Authors:  Rahul Negi; Vemanamanda Haritha; Nuzhat Aziz; Athar H Siddiqui
Journal:  Mol Cell Biochem       Date:  2022-03-16       Impact factor: 3.396

Review 3.  A comprehensive review of hypertension in pregnancy.

Authors:  Reem Mustafa; Sana Ahmed; Anu Gupta; Rocco C Venuto
Journal:  J Pregnancy       Date:  2012-05-23

4.  Predictive value of soluble fms-like tyrosine kinase-1 against placental growth factor for preeclampsia in a Chinese pregnant women population.

Authors:  Fan Yu; Qianjin Bai; Shihong Zhang; Yongmei Jiang
Journal:  J Clin Lab Anal       Date:  2019-02-13       Impact factor: 2.352

5.  Assessment of the Proton Pump Inhibitor, Esomeprazole Magnesium Hydrate and Trihydrate, on Pathophysiological Markers of Preeclampsia in Preclinical Human Models of Disease.

Authors:  Natasha de Alwis; Bianca R Fato; Sally Beard; Natalie K Binder; Tu'uhevaha J Kaitu'u-Lino; Kenji Onda; Natalie J Hannan
Journal:  Int J Mol Sci       Date:  2022-08-23       Impact factor: 6.208

6.  Literature-Informed Analysis of a Genome-Wide Association Study of Gestational Age in Norwegian Women and Children Suggests Involvement of Inflammatory Pathways.

Authors:  Jonas Bacelis; Julius Juodakis; Verena Sengpiel; Ge Zhang; Ronny Myhre; Louis J Muglia; Staffan Nilsson; Bo Jacobsson
Journal:  PLoS One       Date:  2016-08-04       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.